Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Vitamin D therapy.

Jordan L Geller1, John S Adams

  • 1Orthopaedic Hospital Research Center, UCLA-Orthopaedic Hospital Department of Orthopaedic Surgery, David Geffen School of Medicine at UCLA, Mail Stop 735822, 615 Charles E. Young Drive South, Room 410E, Los Angeles, CA 90095, USA.

Current Osteoporosis Reports
|April 24, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spinal Implant-Associated Infection in Type 2 and Type 1 Diabetes: Phenotype-Specific Inflammatory Features and Therapeutic Response to Semaglutide.

JOR spine·2026
Same author

Low Preoperative Platelet Count Is Associated With Deep Surgical Site Infection in Knee Arthroplasty.

Arthroplasty today·2026
Same author

The Impact of Gender-Affirming Hormone Therapy on the Emotional Health of Trans and Nonbinary Youth.

The Journal of adolescent health : official publication of the Society for Adolescent Medicine·2025
Same author

Glucagon-Like Peptide-1 Receptor Agonist Medications Alter Outcomes of Spine Surgery: A Study Among Over 15,000 Patients.

Spine·2025
Same author

Phase 1 study of the pharmacokinetics and clinical proof-of-concept activity of a biofilm-disrupting human monoclonal antibody in patients with chronic prosthetic joint infection of the knee or hip.

Antimicrobial agents and chemotherapy·2024
Same author

<u>Hi</u>gh-<u>T</u>hroughput <u>C</u>AMP <u>A</u>ssay (HiTCA): A Novel Tool for Evaluating the Vitamin D-Dependent Antimicrobial Response.

Nutrients·2023
Same journal

Beyond Fracture Probability: Communicating the Full Consequences of Fracture and Contextualization.

Current osteoporosis reports·2026
Same journal

Time-Lapse HR-pQCT: an in Vivo Imaging-Based Assessment of Bone Remodeling Dynamics.

Current osteoporosis reports·2026
Same journal

Cone Beam Computed Tomography of Bonejaws in Patients With Primary Osteoporosis: A Systematic Review.

Current osteoporosis reports·2026
Same journal

Testosterone and Bone Health in Men.

Current osteoporosis reports·2026
Same journal

Stimulant Medications and Bone Health.

Current osteoporosis reports·2026
Same journal

The Innate and Adaptive Immune Functions of Osteoblast-Lineage Cells.

Current osteoporosis reports·2026
See all related articles

Vitamin D is crucial for bone health, and insufficiency is widespread. New guidelines recommend maintaining serum 25-hydroxyvitamin D levels above 32 ng/dL for patients with osteopenia or osteoporosis.

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Nutritional Science

Background:

  • Vitamin D (ergocalciferol/D2 and cholecalciferol/D3) is vital for calcium and phosphate absorption, essential for bone mineralization.
  • Vitamin D insufficiency is a growing concern, linked to chronic secondary hyperparathyroidism and osteoporosis.
  • The rising incidence of osteoporosis correlates with a global increase in vitamin D deficiency.

Purpose of the Study:

  • To revise and establish updated standards for vitamin D sufficiency.
  • To emphasize the importance of monitoring vitamin D levels in patients with bone conditions.

Main Methods:

  • Review of observational and prospective trials with clinical end points.
  • Analysis of data to determine optimal serum 25-hydroxyvitamin D levels.

Related Experiment Videos

Main Results:

  • Revised standards for vitamin D sufficiency have been established.
  • Recommended serum 25-hydroxyvitamin D levels should exceed 32 ng/dL for individuals with osteopenia or osteoporosis.

Conclusions:

  • Maintaining adequate vitamin D levels is critical for preventing and managing osteoporosis.
  • All patients with osteopenia or osteoporosis require monitoring and potentially supplementation, including those on bisphosphonates or with hyperparathyroidism.